-
-
Risk of Adenocarcinoma in Barretts Esophagus; Long-Term Effect of Doxazosin, Finasteride, and Combination for BPH; Once Daily Valacyclovir to Reduce Herpes Transmission; Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea; Association Between C-reactive Protein and Age-related Macular Degeneration; VZV Reactivation in Astronauts
-
Question: The Centers for Medicare & Medicaid Services (CMS) recently issued guidance to surveyors on interpreting the final EMTALA rule, and one of the points stated that EMTALA no longer applies when the physician determines that no emergency exists. Does this mean that EMTALA no longer applies once the patient has been treated for the presenting emergency and that emergency no longer exists, but then another condition arises or the patient complains of something new?
-
The National Institutes of Health (NIH) wants all research supported with NIH funds to be shared with other investigators and made available to the public, but how can this philosophy be reconciled with privacy laws and concerns?
-
-
A new strategy for hastening treatment for heart attack victims is being tested in a mountainous California county where drive times to hospitals often are long, and the lead researcher says it could become a way for EDs to be their communitys leader in cardiac care.
-
In emergency medicine and critical care, clinical trials are difficult to conduct. The unpredictable and time-sensitive nature of these specialties means that controlled, randomized, clinical trials are difficult, sometimes impossible to design.
-
If the average waiting time in your ED is more than an hour, maybe you could learn a thing or two from ED managers who report that their patients wait less than 60 minutes for treatment.
-
-
This is the radio public service announcement that Baptist Memorial Health Care in Memphis, TN, uses to educate the public about alternatives to using the ED for nonurgent care.